The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Leukemia, B-Cell, Chronic

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Leukemia, B-Cell, Chronic

 

High impact information on Leukemia, B-Cell, Chronic

 

Chemical compound and disease context of Leukemia, B-Cell, Chronic

 

Biological context of Leukemia, B-Cell, Chronic

 

Anatomical context of Leukemia, B-Cell, Chronic

  • We investigated the surface expression of leukocyte differentiation antigens and the Ig heavy-chain variable region (VH) gene family use in leukemic cells from 26 Japanese patients with chronic B-cell leukemias with special reference to CD5 antigen expression [19].
 

Gene context of Leukemia, B-Cell, Chronic

 

Analytical, diagnostic and therapeutic context of Leukemia, B-Cell, Chronic

References

  1. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Wang, Z.G., Rivi, R., Delva, L., König, A., Scheinberg, D.A., Gambacorti-Passerini, C., Gabrilove, J.L., Warrell, R.P., Pandolfi, P.P. Blood (1998) [Pubmed]
  2. Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells. Shimamura, R., Kudo, J., Kondo, H., Dohmen, K., Gondo, H., Okamura, S., Ishibashi, H., Niho, Y. Blood (1990) [Pubmed]
  3. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Huang, M.R., Olsson, M., Kallin, A., Pettersson, U., Tötterman, T.H. Gene Ther. (1997) [Pubmed]
  4. Combination therapy with nucleoside analogs and alkylating agents. Johnston, J.B., Verburg, L., Shore, T., Williams, M., Israels, L.G., Begleiter, A. Leukemia (1994) [Pubmed]
  5. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies. Marinov, J., Koubek, K., Starý, J. Neoplasma (1993) [Pubmed]
  6. Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells. Long, B.W., Witte, P.L., Abraham, G.N., Gregory, S.A., Plate, J.M. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  7. Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. Runarsson, G., Liu, A., Mahshid, Y., Feltenmark, S., Pettersson, A., Klein, E., Björkholm, M., Claesson, H.E. Blood (2005) [Pubmed]
  8. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., Cuneo, A., Castoldi, G., Di Virgilio, F., Baricordi, O.R. Blood (2002) [Pubmed]
  9. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. König, A., Wrazel, L., Warrell, R.P., Rivi, R., Pandolfi, P.P., Jakubowski, A., Gabrilove, J.L. Blood (1997) [Pubmed]
  10. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Döhner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S. Blood (1995) [Pubmed]
  11. Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells. Biswal, S.S., Datta, K., Acquaah-Mensah, G.K., Kehrer, J.P. Toxicology (2000) [Pubmed]
  12. L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia. Böhme, A., Wolter, M., Hoelzer, D. Ann. Hematol. (1998) [Pubmed]
  13. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Billard, C., Izard, J.C., Roman, V., Kern, C., Mathiot, C., Mentz, F., Kolb, J.P. Leuk. Lymphoma (2002) [Pubmed]
  14. XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia. Crossen, P.E., Morrison, M.J. Leukemia (1992) [Pubmed]
  15. Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system? Burton, J., Kay, N.E. Leukemia (1994) [Pubmed]
  16. Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. Döhner, H., Pilz, T., Fischer, K., Cabot, G., Diehl, D., Fink, T., Stilgenbauer, S., Bentz, M., Lichter, P. Leuk. Lymphoma (1994) [Pubmed]
  17. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Kitabayashi, A., Hirokawa, M., Miura, A.B. Int. J. Hematol. (1995) [Pubmed]
  18. Flow cytometry of TPA-induced changes in cells of chronic B-cell leukemias. Munker, R., Ellwart, J., Ziegler-Heitbrock, H.W. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. (1987) [Pubmed]
  19. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia. Ikematsu, W., Ikematsu, H., Okamura, S., Otsuka, T., Harada, M., Niho, Y. Blood (1994) [Pubmed]
  20. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Bauvois, B., Dumont, J., Mathiot, C., Kolb, J.P. Leukemia (2002) [Pubmed]
  21. Heterogeneity in terms of interleukin 4-dependent regulation of Fc epsilon...receptor/CD23 expression on chronic B-lymphocytic leukemia cells. Ishida, H., Kumagai, S., Iwai, K., Takahashi, T., Kawabe, T., Yodoi, J., Arai, N., Namiuchi, S., Konaka, Y., Imura, H. Immunol. Lett. (1989) [Pubmed]
  22. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor. Shiiba, M., Takaki, S., Takatsu, K. Int. Arch. Allergy Immunol. (1996) [Pubmed]
  23. Lack of 5' BCL2 rearrangements in B-cell leukemia. Crossen, P.E., Morrison, M.J. Cancer Genet. Cytogenet. (1993) [Pubmed]
 
WikiGenes - Universities